Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Side-by-Side Comparisons of Important SARS-CoV-2 Variants

Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.

Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.

virology
Special report
A Guide to Emerging SARS-CoV-2 Variants
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
Accelerating Discovery in the Age of a Pandemic
Accelerating Discovery in the Age of a Pandemic
The Scientist Creative Services Team | Jan 22, 2021
An expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Coronavirus Variant Linked to COVID-19 Outbreaks in California
Asher Jones | Jan 19, 2021
It’s too early to know whether the L452R version of SARS-CoV-2 is highly infectious like the B.1.1.7 UK variant that is also spreading around the US.
Past SARS-CoV-2 Infection Mostly Protects Survivors
Past SARS-CoV-2 Infection Mostly Protects Survivors
Max Kozlov | Jan 14, 2021
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Kerry Grens | Jan 8, 2021
An engineered coronavirus with the N501Y mutation—one of many mutations present in the emerging B.1.1.7 and 501.V2 variants of the coronavirus—is neutralized by the sera of COVID-19 vaccine recipients.
First US Case of UK SARS-CoV-2 Variant Detected
First US Case of UK SARS-CoV-2 Variant Detected
Max Kozlov | Dec 30, 2020
Variant B.1.1.7, though likely more contagious than other strains, does not appear to be more deadly.
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist Creative Services Team | Dec 15, 2020
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
Mosquitos in Asia and the Americas More Susceptible to Zika Virus
Mosquitos in Asia and the Americas More Susceptible to Zika Virus
Abby Olena | Nov 19, 2020
A study explains how Zika was present among mosquitoes in Africa for decades without causing the harm to human health seen outside the continent in recent years.
Giant Viruses Can Integrate into the Genomes of Their Hosts
Giant Viruses Can Integrate into the Genomes of Their Hosts
Amanda Heidt | Nov 19, 2020
Rather than introducing small chunks of DNA as other viruses do, some giant viruses can contribute more than 1 million base pairs to a host’s genome, broadening the ways in which viruses may shape eukaryote evolution.